Functional imaging in epilepsy

Seizure

Volumn 10, Issue 2, 2001, Pages 139-156

  Richardson, Mark P ^a,b  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b EPILEPSY SOCIETY   (United Kingdom)

Author keywords

Epilepsy; FMRI; MRS; PET; Review; SPECT

Indexed keywords

BENZODIAZEPINE RECEPTOR; CARBON 11; FLUMAZENIL; OPIATE RECEPTOR; GLUCOSE;

ARTICLE; CLINICAL RESEARCH; COGNITION; CONTROLLED STUDY; DIAGNOSTIC IMAGING; ELECTROENCEPHALOGRAM; EPILEPSY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MEDICAL ASSESSMENT; MEDICAL LITERATURE; MOTOR PERFORMANCE; NEUROBIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TECHNIQUE; BRAIN; BRAIN CIRCULATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; ELECTROENCEPHALOGRAPHY; METABOLISM; PATHOLOGY; PATIENT EDUCATION; PHYSIOLOGY; REVIEW; SELF EVALUATION; VASCULARIZATION;

BRAIN; CEREBROVASCULAR CIRCULATION; ELECTROENCEPHALOGRAPHY; EPILEPSY; GLUCOSE; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; PATIENT EDUCATION; SELF ASSESSMENT (PSYCHOLOGY); TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0035022944     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1053/seiz.2001.0546     Document Type: Article

References (182)

1. Woods R. P., Mazziotta J. C., Cherry S. R. MRI-PET registration with automated algorithm. Journal of Computer Assisted Tomography. 17:1993;536-546.
2. Labbe C., Froment J. C., Kennedy A., Ashburner J., Cinotti L. Positron emission tomography metabolic data corrected for cortical atrophy using magnetic resonance imaging. Alzheimer Disease and Associated Disorders. 10:1996;141-170.
3. Muller Gartner H. W., Links J. M., Prince J. L., Bryan R. N., McVeigh E. et al. Measurement of radiotracer concentration in brain gray matter using positron emission tomography: MRI-based correction for partial volume effects. Journal of Cerebral Blood Flow and Metabolism. 12:1992;571-583.
4. Rousset O. G., Ma Y., Léger G. C., Gjedde A. H., Evans A. C. Correction for partial volume effects in PET using MRI-based 3D simulations of individual human brain metabolism. Uemura K. Quantification of Brain Function, Tracer Kinetics and Image Analysis in Brain PET. 1993;113-125 Elsevier Science, Amsterdam
5. Rousset O. G., Ma Y., Marenco S., Wong D. F., Evans A. C. In vivo correction for partial volume effects in PET: accuracy and precision. Neuroimage. 2:1995.
6. Frost J. J., Meltzer C. C., Zubieta J. K., Links J. M., Brakeman P. et al. MR-based correction of brain PET measurements for heterogeneous gray matter radioactivity distribution. Neuroimage. 2:1995.
7. Frost J. J., Meltzer C. C., Zubieta J. K., Links J. M., Brakeman P. et al. MR-based correction of partial volume effects in brain PET imaging. Quantification of Brain Function Using PET. 1996;Academic Press, London.
8. Koepp M. J., Richardson M. P., Labbe C., Brooks D. J., Cunningham V. J. et al. C-11-flumazenil PET, volumetric MRI, and quantitative pathology in mesial temporal lobe epilepsy. Neurology. 49:1997;764-773.
9. Koepp M. J., Richardson M. P., Brooks D. J., Poline J. B., Friston K. J. et al. Cerebral benzodiazepine receptors in hippocampal sclerosis: an objective in vivo analysis. Brain. 119:1996;1677-1687.
10. Richardson M. P., Koepp M. J., Fish D. R., Brooks D. J., Duncan J. S. Benzodiazepine receptors in focal epilepsy with cortical dysgenesis: an 11C-flumazenil PET study. Annals of Neurology. 40:1996;188-198.
11. Friston K. J., Holmes A. P., Worsley K. J., Poline J. B., Frith C. D. et al. Statistical parametric maps in functional imaging: a general linear approach. Human Brain Mapping. 2:1995;189-210.
12. Richardson M. P., Friston K. J., Sisodiya S. M., Koepp M. J., Ashburner J. et al. Cortical grey matter and benzodiazepine receptors in malformations of cortical development: a voxel-based comparison of structural and functional imaging data. Brain. 120:1997;1961-1973.
13. Duncan J. S. Imaging and epilepsy. Brain. 120:1997;376-389.
14. Bookheimer S. Y. Functional MRI applications in clinical epilepsy. Neuroimage. 4:1996;S139-S146.
15. Bookheimer S. Y., Dapretto M., Karmarkar U. Functional MRI in children with epilepsy. Developmental Neuroscience. 21:1999;191-199.
16. Michel C. M., Grave de Peralta R., Lantz G., Gonzalez Andino S., Spinelli L. et al. Spatiotemporal EEG analysis and distributed source estimation in presurgical epilepsy evaluation. Journal of Clinical Neurophysiology. 16:1999;239-266.
17. Jackson G. D., Connelly A., Cross J. H., Gordon I., Gadian D. G. Functional magnetic resonance imaging of focal seizures. Neurology. 44:1994;850-856.
18. Detre J. A., Sirven J. I., Alsop D. C., O'Connor M. J., French J. A. Localization of subclinical ictal activity by functional magnetic resonance imaging: correlation with invasive monitoring. Annals of Neurology. 38:1995;618-624.
19. Detre J. A., Alsop D. C., Aguirre G. K., Sperling M. R. Coupling of cortical and thalamic ictal activity in human partial epilepsy: demonstration by functional magnetic resonance imaging. Epilepsia. 37:1996;657-661.
20. Warach S., Ives J., Schlaug G., Patel M., Darby D. EEG-triggered echoplanar functional MRI in epilepsy. Neurology. 47:1996;89-93.
21. Symms M. R., Allen P. J., Woermann F. G., Polizzi G., Krakow K. et al. Reproducible localization of interictal epileptiform discharges using EEG-triggered fMRI. Physics in Medicine and Biology. 44:1999;N161-N168.
22. Allen P. J., Polizzi G., Krakow K., Fish D. R., Lemieux L. Identification of EEG events in the MR scanner: the problem of pulse artifact and a method for its subtraction. Neuroimage. 8:1998;229-239.
23. Huanghellinger F. R., Breiter H. C., McCormack G., Cohen M. S., Kwong K. K. et al. Simultaneous functional magnetic-resonance-imaging and electrophysiological recording. Human Brain Mapping. 3:1995;13-23.
24. Lemieux L., Allen P. J., Franconi F., Symms J. M. R., Fish D. R. Recording of EEG during fMRI experiments: patient safety. Magnetic Resonance in Medicine. 38:1997;943-952.
25. Krakow K., Woermann F. G., Symms M. R., Allen P. J., Lemieux L. et al. EEG-triggered functional MRI of interictal epileptiform activity in patients with partial seizures. Brain. 122:1999;1679-1688.
26. Lazeyras F., Blanke O., Perrig S., Zimine I., Golay X. et al. EEG-triggered functional MRI in patients with pharmacoresistant epilepsy. Journal of Magnetic Resonance Imaging. 12:2000;177-185.
27. Patel M. R., Blum A., Pearlman J. D., Yousuf N., Ives J. R. et al. Echo-planar functional MR imaging of epilepsy with concurrent EEG monitoring. AJNR. American Journal of Neuroradiology. 20:1999;1916-1919.
28. Morris G. L., Mueller W. M., Yetkin F. Z., Haughton V. M., Hammeke T. A. et al. Functional magnetic-resonance-imaging in partial epilepsy. Epilepsia. 35:1994;1194-1198.
29. Desmond J. E., Sum J. M., Wagner A. D., Demb J. B., Shear P. K. et al. Functional MRI measurement of language lateralization in Wada-tested patients. Brain. 118:1995;1411-1419.
30. Alsop D. C., Detre J. A., D'Esposito M., Howard R. S., Maldjian J. A. et al. Functional activation during an auditory comprehension task in patients with temporal lobe lesions. Neuroimage. 4:1996;55-59.
31. Binder J. R., Swanson S. J., Hammeke T. A., Morris G. L., Mueller W. M. et al. Determination of language dominance using functional MRI: a comparison with the Wada test. Neurology. 46:1996;978-984.
32. Hertz-Pannier L., Gaillard W. D., Mott S. H., Cuenod C. A., Bookheimer S. Y. et al. Noninvasive assessment of language dominance in children and adolescents with functional MRI: a preliminary study. Neurology. 48:1997;1003-1012.
33. Worthington C., Vincent D. J., Bryant A. E., Roberts D. R., Vera C. L. et al. Comparison of functional magnetic resonance imaging for language localization and intracarotid speech amytal testing in presurgical evaluation for intractable epilepsy. Preliminary results. Stereotactic and Functional Neurosurgery. 69:1997;197-201.
34. Bellgowan P. S., Binder J. R., Swanson S. J., Hammeke T. A., Springer J. A. et al. Side of seizure focus predicts left medial temporal lobe activation during verbal encoding. Neurology. 51:1998;479-484.
35. Benson R. R., FitzGerald D. B., LeSueur L. L., Kennedy D. N., Kwong K. K. et al. Language dominance determined by whole brain functional MRI in patients with brain lesions. Neurology. 52:1999;798-809.
36. Detre J. A., Maccotta L., King D., Alsop D. C., Glosser G. et al. Functional MRI lateralization of memory in temporal lobe epilepsy. Neurology. 50:1998;926-932.
37. Dupont S., Van de Moortele P. F., Samson S., Hasboun D., Poline J. B. et al. Episodic memory in left temporal lobe epilepsy: a functional MRI study. Brain. 123:2000;1722-1732.
38. Urenjak J., Williams S. R., Gadian D. G., Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. Journal of Neuroscience. 13:1993;981-989.
39. Connelly A., Jackson G. D., Duncan J. S., King M. D., Gadian D. G. Magnetic resonance spectroscopy in temporal lobe epilepsy. Neurology. 44:1994;1411-1417.
40. Gadian D. G., Connelly A., Duncan J. S., Cross J. H., Kirkham F. J. et al. 1H Magnetic resonance spectroscopy in the investigation of intractable epilepsy. Acta Neurologica Scandinavica. 89 (Suppl. 152):1994;116-122.
41. Cross J. H., Connelly A., Jackson G. D., Johnson C. L., Neville B. G. R. et al. Proton magnetic resonance spectroscopy in children with temporal lobe epilepsy. Annals of Neurology. 39:1996;107-113.
42. Lu D. F., Margouleff C., Rubin E., Labar D., Schaul N. et al. Temporal lobe epilepsy: correlation of proton magnetic resonance spectroscopy and F-18-fluorodeoxyglucose positron emission tomography. Magnetic Resonance in Medicine. 37:1997;18-23.
43. Cross J. H., Gordon I., Connelly A., Jackson G. D., Johnson C. L. et al. Interictal Tc-99(m) HMPAO SPECT and H-1 MRS in children with temporal lobe epilepsy. Epilepsia. 38:1997;338-345.
44. Hugg J. W., Kuzniecky R. I., Gilliam F. G., Morawetz R. B., Fraught R. E. et al. Normalization of contralateral metabolic function following temporal lobectomy demonstrated by 1H magnetic resonance spectroscopic imaging. Annals of Neurology. 40:1996;236-239.
45. Xue M., Ng T. C., Comair Y. G., Modic M., Luders H. Presurgical localization of temporal lobe epilepsy using noninvasive proton chemical shift spectroscopic imaging. Society of Magnetic Resonance in Medicine. 1994;Book of Abstracts.
46. Cendes F., Andermann F., Preu L. M. C., Arnold D. L. Lateralization of temporal lobe epilepsy based on regional metabolic abnormalities in proton magnetic resonance spectroscopic images. Annals of Neurology. 35:1994;211-216.
47. Cendes F., Caramanos Z., Andermann F., Dubeau F., Arnold D. L. Proton magnetic resonance spectroscopic imaging and magnetic resonance imaging volumetry in the lateralization of temporal lobe epilepsy: a series of 100 patients. Annals of Neurology. 42:1997;737-746.
48. Hetherington H., Kuzniecky R., Pan J., Mason G., Morawetz R. et al. Proton nuclear magnetic resonance spectroscopic imaging of human temporal lobe epilepsy at 4.1T. Annals of Neurology. 38:1995;396-404.
49. Vermathen P., Ende G., Laxer K. D., Knowlton R. C., Matson G. B. et al. Hippocampal N-acetylaspartate in neocortical epilepsy and mesial temporal lobe epilepsy. Annals of Neurology. 42:1997;194-199.
50. Incisa della Rocchetta A., Gadian D. G., Connelly A., Polkey C. E., Jackson G. D. et al. Verbal memory impairment after right temporal lobe surgery: role of contralateral damage as revealed by 1H magnetic resonance spectroscopy and T2 relaxometry. Neurology. 45:1995;797-802.
51. Gadian D. G., Isaacs E. B., Cross J. H., Connelly A., Jackson G. D. et al. Lateralization of brain-function in childhood revealed by magnetic-resonance spectroscopy. Neurology. 46:1996;974-977.
52. Ng T. C., Comair Y. G., Xue M., So N., Majors A. et al. Temporal lobe epilepsy: presurgical localization with proton chemical shift imaging. Radiology. 193:1994;465-472.
53. Cendes F., Stanley J. A., Dubeau F., Andermann F., Arnold D. L. Proton magnetic resonance spectroscopic imaging for discrimination of absence and complex partial seizures. Annals of Neurology. 41:1997;74-81.
54. Rothman D. L., Petroff O. A. C., Behar K. L., Mattson R. H. Localized 1H NMR measurements of g-aminobutyric acid in human brain in vivo. Proceedings of the National Academy of Sciences of the United States of America. 90:1993;5662-5666.
55. Petroff O. A. C., Rothman D. L., Behar K. L., Mattson R. H. Initial observations on the effect of vigabatrin on in vivo 1H spectroscopic measurements of GABA, glutamate and glutamine in human brain. Epilepsia. 36:1995;457-464.
56. Petroff O. A. C., Rothman D. L., Behar K. L., Mattson R. H. Initial observations on the effect of gabapentin on brain GABA in patients with epilepsy. Annals of Neurology. 39:1996;95-99.
57. Laxer K. D., Hubesch B., Sappey-Marinier D., Weiner M. W. Increased pH and inorganic phosphate in temporal seizure foci demonstrated by [31P]MRS. Epilepsia. 33:1992;618-623.
58. Hugg J. W., Laxer K. D., Matson G. B., Maudsley A. A., Husted C. A. et al. Lateralization of human focal epilepsy by 31P magnetic resonance spectroscopic imaging. Neurology. 42:1992;2011-2018.
59. Bonte F. J., Devous M. D. Sr, Stokely E. M., Homan R. W. Single-photon tomographic determination of regional cerebral blood flow in epilepsy. AJNR. American Journal of Neuroradiology. 4:1983;544-546.
60. ′-(2 hydroxy-3-methyl-5-123I-iodobenzyl)-1,3-propanediamine 2 HCl (HIPDM): intractable complex partial seizures. Neurology. 36:1986;1471-1477.
61. Lee B. I., Markand O. N., Wellman H. N., Siddiqui A. R., Mock. HIPDM single photon emission computed tomography brain imaging in partial onset secondarily generalized tonic-clonic seizures. Epilepsia. 28:1987;305-311.
62. Lee B. I., Markand O. N., Wellman H. N., Siddiqui A. R., Park H. M. et al. HIPDM-SPECT in patients with medically intractable complex partial seizures. Ictal study. Archives of Neurology. 45:1988;397-402.
63. Stefan H., Kuhnen C., Biersack H. J., Reichmann K. Initial experience with 99m Tc-hexamethyl-propylene amine oxime (HM-PAO) single photon emission computed tomography (SPECT) in patients with focal epilepsy. Epilepsy Research. 1:1987;134-138.
64. Stefan H., Pawlik G., Bocher Schwarz H. G., Biersack H. J., Burr W. et al. Functional and morphological abnormalities in temporal lobe epilepsy: a comparison of interictal and ictal EEG, CT, MRI, SPECT and PET. Journal of Neurology. 234:1987;377-384.
65. Denays R., Rubinstein M., Ham H., Piepsz A., Noel P. Single photon emission computed tomography in seizure disorders. Archives of Disease in Childhood. 63:1988;1184-1188.
66. Pantano P., Matteucci C., di Piero V., Pozzilli C., Faedda M. T. et al. Quantitative assessment of cerebral blood flow in partial epilepsy using Xe-133 inhalation and SPECT. Clinical Nuclear Medicine. 16:1991;898-903.
67. Podreka I., Lang W., Suess E., Wimberger D., Steiner M. et al. Hexa-methyl-propylene-amine-oxime (HMPAO) single photon emission computed tomography (SPECT) in epilepsy. Brain Topography. 1:1988;55-60.
68. Kawamura M., Murase K., Kimura H., Hatakeyama T., Mogami H. et al. Single photon emission computed tomography (SPECT) using N-isopropyl-p-(123I) iodoamphetamine (IMP) in the evaluation of patients with epileptic seizures. European Journal of Nuclear Medicine. 16:1990;285-292.
69. Rowe C. C., Berkovic S. F., Austin M. C., Saling M., Kalnins R. M. et al. Visual and quantitative analysis of interictal SPECT with technetium-99m-HMPAO in temporal lobe epilepsy. Journal of Nuclear Medicine. 32:1991;1688-1694.
70. Jibiki I., Kubota T., Fujimoto K., Yamaguchi N., Matsuda H. et al. Regional relationships between focal hypofixation images in 123I-IMP single photon emission computed tomography and epileptic EEG foci in interictal periods in patients with partial epilepsy. European Neurology. 31:1991;360-365.
71. Duncan S., Gillen G., Adams F. G., Duncan R., Brodie M. J. Interictal HM-PAO SPECT: a routine investigation in patients with medically intractable complex partial seizures? Epilepsy Research. 13:1992;83-87.
72. Spencer S. S. The relative contributions of MRI, SPECT, and PET imaging in epilepsy. Epilepsia. 35 (Suppl. 6):1994;S72-S89.
73. Tatum W. O., Oconnor M. J., Sperling M. R., Jacobstein J. G. Interictal single-photon emission computed-tomography in partial epilepsy - accuracy in localization and prediction of outcome. Journal of Neuroimaging. 5:1995;142-144.
74. Shen W., Lee B. I., Park H. M., Siddiqui A. R., Wellman H. H. et al. HIPDM-SPECT brain imaging in the presurgical evaluation of patients with intractable seizures. Journal of Nuclear Medicine. 31:1990;1280-1284.
75. Bauer J., Stefan H., Feistel H., Schuler P., Platsch G. et al. Ictal and interictal 99mTc-HMPAO-SPECT studies in temporal lobe epilepsy with unilateral EEG focus. Nervenarzt. 62:1991;745-749.
76. Markand O. N., Shen W., Park H. M., Siddiqui A. R., Wellman H. H. et al. Single photon imaging computed tomography (SPECT) for localization of epileptogenic focus in patients with intractable complex partial seizures. Epilepsy Research (Supplement). 5:1992;121-126.
77. Newton M. R., Austin M. C., Chan J. G., McKay W. J., Rowe C. C. et al. Ictal SPECT using technetium-99m-HMPAO: methods for rapid preparation and optimal deployment of tracer during spontaneous seizures. Journal of Nuclear Medicine. 34:1993;666-670.
78. Duncan R., Patterson J., Roberts R., Hadley D. M., Bone I. Ictal/postictal SPECT in the pre-surgical localisation of complex partial seizures. Journal of Neurology, Neurosurgery and Psychiatry. 56:1993;141-148.
79. Harvey A. S., Bowe J. M., Hopkins I. J., Shield L. K., Cook D. J. et al. Ictal 99mTc-HMPAO single photon emission computed tomography in children with temporal lobe epilepsy. Epilepsia. 34:1993;869-877.
80. Markand O. N., Salanova V., Worth R. M., Park H. M., Wellman H. H. Ictal brain imaging in presurgical evaluation of patients with medically intractable complex partial seizures. Acta Neurologica Scandinavica (Supplementum). 152:1994;137-144.
81. Cross J. H., Gordon I., Jackson G. D., Boyd S. G., Todd-Pokropek A. et al. Children with intractable focal epilepsy: ictal and interictal 99TcM HMPAO single photon emission computed tomography. Developmental Medicine and Child Neurology. 37:1995;673-681.
82. Newton M. R., Berkovic S. F., Austin M. C., Rowe C. C., McKay W. J. et al. SPECT in the localisation of extratemporal and temporal seizure foci. Journal of Neurology, Neurosurgery and Psychiatry. 59:1995;26-30.
83. Marks D. A., Katz A., Hoffer P., Spencer S. S. Localization of extratemporal epileptic foci during ictal single photon emission computed tomography. Annals of Neurology. 31:1992;250-255.
84. Harvey A. S., Hopkins I. J., Bowe J. M., Cook D. J., Shield L. K. et al. Frontal lobe epilepsy: clinical seizure characteristics and localization with ictal 99mTc-HMPAO SPECT. Neurology. 43:1993;1966-1980.
85. Rowe C. C., Berkovic S. F., Austin M. C., McKay W. J., Bladin P. F. Patterns of postictal cerebral blood flow in temporal lobe epilepsy: qualitative and quantitative analysis. Neurology. 41:1991;1096-1103.
86. Otsubo H., Hwang P. A., Gilday D. L., Hoffman H. J. Location of epileptic foci on interictal and immediate postictal single-photon emission tomography in children with localization-related epilepsy. Journal of Child Neurology. 10:1995;375-381.
87. Zubal I. G., Spencer S. S., Imam K., Seibyl J., Smith E. O. et al. Difference images calculated from ictal and interictal technetium-99m-HMPAO SPECT scans of epilepsy. Journal of Nuclear Medicine. 36:1995;684-689.
88. O'Brien T. J., So E. L., Mullan B. P., Hauser M. F., Brinkmann B. H. et al. Subtraction ictal SPECT co-registered to MRI improves clinical usefulness of SPECT in localizing the surgical seizure focus. Neurology. 50:1998;445-454.
89. O'Brien T J., Oconnor M. K., Mullan B. P., Brinkmann B. H., Hanson D. et al. Subtraction ictal SPET co-registered to MRI in partial epilepsy: description and technical validation of the method with phantom and patient studies. Nuclear Medicine Communications. 19:1998;31-45.
90. Homan R. W., Paulman R. G., Devous M. D. Sr, Walker P., Jennings L. W. et al. Cognitive function and regional cerebral blood flow in partial seizures. Archives of Neurology. 46:1989;964-970.
91. LaManna M. M., Sussman N. M., Harner R. N., Kaplan L. R., Hershey B. L. et al. Initial experience with SPECT imaging of the brain using I-123 p-iodoamphetamine in focal epilepsy. Clinical Nuclear Medicine. 14:1989;428-430.
92. Newton M. R., Berkovic S. F., Austin M. C., Rowe C. C., McKay W. J. et al. Postictal switch in blood flow distribution and temporal lobe seizures. Journal of Neurology, Neurosurgery and Psychiatry. 55:1992;891-894.
93. Park C. H., Kim S. M., Streletz L. J., Zhang J., Intenzo C. Reverse crossed cerebellar diaschisis in partial complex seizures related to herpes simplex encephalitis. Clinical Nuclear Medicine. 17:1992;732-735.
94. Katz A., Bose A., Lind S. J., Spencer S. S. SPECT in patients with epilepsia partialis continua. Neurology. 40:1990;1848-1850.
95. Newton M. R., Berkovic S. F., Austin M. C., Reutens D. C., McKay W. J. et al. Dystonia, clinical lateralization, and regional blood flow changes in temporal lobe seizures. Neurology. 42:1992;371-377.
96. Ho S. S., Berkovic S. F., McKay W. J., Kalnins R. M., Bladin P. F. Temporal-lobe epilepsy subtypes, differential patterns of cerebral perfusion on ictal spect. Epilepsia. 37:1996;788-795.
97. Holl K., Deisenhammer E., Dauth J., Carmann H., Schubiger P. A. Imaging benzodiazepine receptors in the human brain by single photon emission computed tomography (SPECT). International Journal of Radiation Applications and Instrumentation B. 16:1989;759-763.
98. Schubiger P. A., Hasler P. H., Beer Wohlfahrt H., Bekier A., Oettli R. et al. Evaluation of a multicentre study with Iomazenil - a benzodiazepine receptor ligand. Nuclear Medicine Communications. 12:1991;569-582.
99. Bartenstein P., Ludolph A., Schober O., Lottes G., Scheidhauer K. et al. Benzodiazepine receptors and cerebral blood flow in partial epilepsy. European Journal of Nuclear Medicine. 18:1991;111-118.
100. Cordes M., Henkes H., Ferstl F., Schmitz B., Hierholzer J. et al. Evaluation of focal epilepsy: a SPECT scanning comparison of 123-I-iomazenil versus HM-PAO. AJNR. American Journal of Neuroradiology. 13:1992;249-253.
101. Duncan S., Gillen G. J., Brodie M. J. Lack of effect of concomitant clobazam on interictal 123I-iomazenil SPECT. Epilepsy Research. 15:1993;61-66.
102. Venz S., Cordes M., Schmitz B., Hierholzer J., Siekmann R. et al. 123I-iomazenil- and 99mTc-HMPAO in the diagnosis of focal epilepsies: a comparison of untreated and treated patients. Nuklearmedizin. 33:1994;1-7.
103. Sjoholm H., Rosen I., Elmqvist D. Role of I-123-iomazenil SPECT imaging in drug resistant epilepsy with complex partial seizures. Acta Neurologica Scandinavica. 92:1995;41-48.
104. Bartenstein P., Lehmenkuhler C., Sciuk J., Schuierer G. Cortical dysplasia as an epileptogenic focus: reduced binding of 123I-iomezanil with barely perceptible 99mTc-HMPAO SPECT. Nuklearmedizin. 31:1992;142-144.
105. Jibiki I., Kurokawa K., Matsuda H., Fukushima T., Tsuji S. et al. Comparison of benzodiazepine receptor and regional cerebral blood flow imaging of epileptiform foci in hippocampal kindled rabbits: a preliminary report. Pharmacology, Biochemisty and Behavior. 48:1994;553-556.
106. al Tikriti M. S., Dey H. M., Zoghbi S. S., Baldwin R. M., Zea Ponce Y. et al. Dual-isotope autoradiographic measurement of regional blood flow and benzodiazepine receptor availability following unilateral middle cerebral artery occlusion. European Journal of Nuclear Medicine. 21:1994;196-202.
107. Abi Dargham A., Laruelle M, Seibyl J., Rattner Z., Baldwin R. M. SPECT measurement of benzodiazepine receptors in human brain with iodine-123-iomazenil: kinetic and equilibrium paradigms. Journal of Nuclear Medicine. 35:1994;228-238.
108. Laruelle M., Abi Dargham A., al Tikriti M. S., Baldwin R. M., Zea Ponce Y. et al. SPECT quantification of [123I]iomazenil binding to benzodiazepine receptors in nonhuman primates: II. Equilibrium analysis of constant infusion experiments and correlation with in vitro parameters. Journal of Cerebral Blood Flow and Metabolism. 14:1994;453-465.
109. Laruelle M., Baldwin R. M., Rattner Z., al Tikriti M. S., Zea Ponce Y. et al. SPECT quantification of [123I]iomazenil binding to benzodiazepine receptors in nonhuman primates: I. Kinetic modeling of single bolus experiments. Journal of Cerebral Blood Flow and Metabolism. 14:1994;439-452.
110. Franceschi M., Lucignani G., Del Sole A., Grana C., Bressi S. et al. Increased interictal cerebral glucose metabolism in a cortical-subcortical network in drug naive patients with cryptogenic temporal lobe epilepsy. Journal of Neurology, Neurosurgery and Psychiatry. 59:1995;427-431.
111. Kuhl D. E., Engel J., Phelps M. E., Selin C. Epileptic patterns of local cerebral metabolism and perfusion in humans determined by emission computed tomography of 18FDG and 13NH3. Annals of Neurology. 8:1980;348-360.
112. Engel J., Kuhl D. E., Phelps M. E., Crandall P. H. Comparative localization of epileptic foci in partial epilepsy by PET and EEG. Annals of Neurology. 12:1982;529-537.
113. Engel J., Brown W. G., Kuhl D. E., Phelps M. E., Mazziota J. C. et al. Pathological findings underlying focal temporal hypometabolism in partial epilepsy. Annals of Neurology. 12:1982;518-528.
114. Engel J., Kuhl D. E., Phelps M. E., Mazziotta J. C. Interictal cerebral glucose metabolism in partial epilepsy and its relation to EEG changes. Annals of Neurology. 12:1982;510-517.
115. Theodore W. H., Newmark M. E., Sato S., Brooks R., Patronas N. et al. 18F-fluorodeoxyglucose positron emission tomography in refractory complex partial seizures. Annals of Neurology. 14:1983;429-437.
116. Abou Khalil B. W., Siegel G. J., Sackellares J. C., Gilman S., Hichwa R. et al. Positron emission tomography studies of cerebral glucose metabolism in chronic partial epilepsy. Annals of Neurology. 22:1987;480-486.
117. Franck G., Sadzot B., Salmon E., Depresseux J. C., Grisar T. et al. Regional cerebral blood flow and metabolic rates in human focal epilepsy and status epilepticus. Advances in Neurology. 44:1986;935-948.
118. Ryvlin P., Cinotti L., Froment J. C., Le Bars D., Landais P. et al. Metabolic patterns associated with non-specific magnetic resonance imaging abnormalities in temporal lobe epilepsy. Brain. 114:1991;2363-2383.
119. Sadzot B., Debets R. M., Maquet P., van Veelen C. W., Salmon E. et al. Regional brain glucose metabolism in patients with complex partial seizures investigated by intracranial EEG. Epilepsy Research. 12:1992;121-129.
120. Olson D. M., Chugani H. T., Shewmon D. A., Phelps M. E., Peacock W. J. Electrocorticographic confirmation of focal positron emission tomographic abnormalities in children with intractable epilepsy. Epilepsia. 31:1990;731-739.
121. Henry T. R., Mazziotta J. C., Engel J., Jr, Christenson P. D., Zhang J. X. et al. Quantifying interictal metabolic activity in human temporal lobe epilepsy. Journal of Cerebral Blood Flow and Metabolism. 10:1990;748-757.
122. Swartz B. E., Halgren E., Delgado Escueta A. V., Mandelkern M., Gee M. et al. Neuroimaging in patients with seizures of probable frontal lobe origin. Epilepsia. 30:1989;547-558.
123. Henry T. R., Sutherling W. W., Engel J., Jr, Risinger M. W., Levesque M. F. et al. Interictal cerebral metabolism in partial epilepsies of neocortical origin. Epilepsy Research. 10:1991;174-182.
124. Radtke R. A., Hanson M. W., Hoffman J. M., Crain B. J., Walczak T. S. et al. Temporal lobe hypometabolism on PET: predictor of seizure control after temporal lobectomy. Neurology. 43:1993;1088-1092.
125. Theodore W. H., Sato S., Kufta C., Balish M. B., Bromfield E. B. et al. Temporal lobectomy for uncontrolled seizures: the role of positron emission tomography. Annals of Neurology. 32:1992;789-794.
126. Manno E. M., Sperling M. R., Ding X., Jaggi J., Alavi A. et al. Predictors of outcome after anterior temporal lobectomy: positron emission tomography. Neurology. 44:1994;2331-2336.
127. Chee M. W., Morris H. H., Antar M. A., Van Ness P. C., Dinner D. S. et al. Presurgical evaluation of temporal lobe epilepsy using interictal temporal spikes and positron emission tomography. Archives of Neurology. 50:1993;45-48.
128. Debets R. M., van Veelen C. W., Maquet P., van Huffelen A. C., van Emde Boas W. et al. Quantitative analysis of 18FDG-PET in the presurgical evaluation of patients suffering from refractory partial epilepsy. Comparison with CT, MRI, and combined subdural and depth EEG. Acta Neurochirurgica (Supplementum). 50:1990;88-94.
129. Engel J., Jr, Henry T. R., Risinger M. W., Mazziotta J. C., Sutherling W. W. et al. Presurgical evaluation for partial epilepsy: relative contributions of chronic depth-electrode recordings versus FDG-PET and scalp-sphenoidal ictal EEG. Neurology. 40:1990;1670-1677.
130. Ryvlin P., Philippon B., Cinotti L., Froment J. C., Le Bars D. et al. Functional neuroimaging strategy in temporal lobe epilepsy: a comparative study of 18FDG-PET and 99mTc-HMPAO-SPECT. Annals of Neurology. 31:1992;650-656.
131. Gaillard W. D., Bhatia S., Bookheimer S. Y., Fazilat S., Sato S. et al. FDG-PET and volumetric MRI in the evaluation of patients with partial epilepsy. Neurology. 45:1995;123-126.
132. Theodore W. H., Fishbein D., Dietz M., Baldwin P., Deitz M. Complex partial seizures: cerebellar metabolism. Epilepsia. 28:1987;319-323.
133. Pawlik G., Fink G. R., Kessler J., Heiss W. D. PET and functional testing in temporal lobe epilepsy. Acta Neurologica Scandinavica (Supplementum). 152:1994;150-156.
134. Chugani H. T., Mazziotta J. C., Engel J., Jr, Phelps M. E. The Lennox-Gastaut syndrome: metabolic subtypes determined by 2-deoxy-2[18F]fluoro-D-glucose positron emission tomography. Annals of Neurology. 21:1987;4-13.
135. Chugani H. T., Shewmon D. A., Peacock W. J., Shields W. D., Mazziotta J. C. et al. Surgical treatment of intractable neonatal-onset seizures: the role of positron emission tomography. Neurology. 38:1988;1178-1188.
136. Chugani H. T., Shields W. D., Shewmon D. A., Olson D. M., Phelps M. E. et al. Infantile spasms: I. PET identifies focal cortical dysgenesis in cryptogenic cases for surgical treatment [see comments]. Annals of Neurology. 27:1990;406-413.
137. Hajek M., Antonini A., Leenders K. L., Wieser H. G. Mesiobasal versus lateral temporal lobe epilepsy: metabolic differences in the temporal lobe shown by interictal 18F-FDG positron emission tomography. Neurology. 43:1993;79-86.
138. Holmes M. D., Kelly K., Theodore W. H. Complex partial seizures. Correlation of clinical and metabolic features. Archives of Neurology. 45:1988;1191-1193.
139. Henry T. R., Mazziotta J. C., Engel J. Interictal metabolic anatomy of mesial temporal lobe epilepsy. Archives of Neurology. 50:1993;582-589.
140. Sperling M. R., Gur R. C., Alavi A., Gur R. E., Resnick S. et al. Subcortical metabolic alterations in partial epilepsy. Epilepsia. 31:1990;145-155.
141. Rausch R., Henry T. R., Ary C. M., Engel J., Jr, Mazziotta J. Asymmetric interictal glucose hypometabolism and cognitive performance in epileptic patients. Archives of Neurology. 51:1994;139-144.
142. Hajek M., Wieser H. G., Khan N., Antonini A., Schrott P. R. et al. Preoperative and postoperative glucose consumption in mesiobasal and lateral temporal lobe epilepsy. Neurology. 44:1994;2125-2132.
143. Miura K., Watanabe K., Maeda N., Matsumoto A., Kumagai T. et al. Magnetic resonance imaging and positron emission tomography of band heterotopia. Brain and Development. 15:1993;288-290.
144. De Volder A. G., Gadisseux J. F., Michel C. J., Maloteaux J. M., Bol A. C. et al. Brain glucose utilization in band heterotopia: synaptic activity of "double cortex" Pediatric Neurology. 11:1994;290-294.
145. Bairamian D., Di Chiro G., Theodore W. H., Holmes M. D., Dorwart R. H. et al. MR imaging and positron emission tomography of cortical heterotopia. Journal of Computer Assisted Tomography. 9:1985;1137-1139.
146. Falconer J., Wada J. A., Martin W., Li D. PET, CT, and MRI imaging of neuronal migration anomalies in epileptic patients. Canadian Journal of Neurological Sciences. 17:1990;35-39.
147. Lee N., Radtke R. A., Gray L., Burger P. C., Montine T. J. et al. Neuronal migration disorders: positron emission tomography correlations. Annals of Neurology. 35:1994;290-297.
148. Rintahaka P. J., Chugani H. T., Messa C., Phelps M. E. Hemimegalencephaly: evaluation with positron emission tomography. Pediatric Neurology. 9:1993;21-28.
149. Szelies B., Herholz K., Heiss W. D., Rackl A., Pawlik G. et al. Hypometabolic cortical lesions in tuberous sclerosis with epilepsy: demonstration by positron emission tomography. Journal of Computer Assisted Tomography. 7:1983;946-953.
150. Theodore W. H., Holmes M. D., Dorwart R. H., Porter R. J., Di Chiro G. et al. Complex partial seizures: cerebral structure and cerebral function. Epilepsia. 27:1986;576-582.
151. Calabrese P., Fink G. R., Markowitsch H. J., Kessler J., Durwen H. F. et al. Left hemispheric neuronal heterotopia: a PET, MRI, EEG and neuropsychological investigation of a university student. Neurology. 44:1994;302-305.
152. Chugani H. T., Rintahaka P. J., Shewmon D. A. Ictal patterns of cerebral glucose utilization in children with epilepsy. Epilepsia. 35:1994;813-822.
153. Hajek M., Antonini A., Leenders K. L., Wieser H. G. Epilepsia partialis continua studied by PET. Epilepsy Research. 9:1991;44-48.
154. Leiderman D. B., Albert P., Balish M., Bromfield E., Theodore W. H. The dynamics of metabolic change following seizures as measured by positron emission tomography with fluoro-deoxyglucose F18. Archives of Neurology. 51:1994;932-936.
155. Savic I., Persson A., Roland P., Pauli S., Sedvall G. et al. In-vivo demonstration of reduced benzodiazepine receptor binding in human epileptic foci. Lancet. 2:1988;863-866.
156. Savic I., Ingvar M., Stone Elander S. Comparison of [11C]flumazenil and [18F]FDG as PET markers of epileptic foci. Journal of Neurology, Neurosurgery and Psychiatry. 56:1993;615-621.
157. Sadzot B., Debets R. M., Delfiore G., Van Huffelen C. W., Van Veelen A. C. et al. [11C]Flumazenil positron emission tomography: an in vivo marker of neuronal loss in temporal lobe epilepsy. Epilepsia. 35:1994;29.
158. Henry T. R., Frey K. A., Sackellares J. C., Gilman S., Koeppe R. A. et al. In vivo cerebral metabolism and central benzodiazepine-receptor binding in temporal lobe epilepsy. Neurology. 43:1993;1998-2006.
159. Koepp M. J., Hand K. S. P., Labbe C., Richardson M. P., Van Paesschen W. et al. In-vivo 11C-flumazenil PET correlates with ex-vivo 3H-flumazenil
160. Labbe C., Koepp M., Ashburner J., Spinks T., Richardson M. et al. Absolute PET quantification with correction for partial volume effects within cerebral structures. Carson R. E., Herscovitch P., Daube-Witherspoon M. Quantitative Functional Brain Imaging with Positron Emission Tomography. 1998;59-66 Academic Press, San Diego.
161. Koepp M. J., Labbé C., Richardson M. P., Brooks D. J., Van Paesschen W. et al. Regional hippocampal [11C]flumazenil PET in temporal lobe epilepsy with unilateral and bilateral hippocampal sclerosis. Brain. 120:1997;1865-1876.
162. Savic I., Thorell J. O., Roland P. [11C]Flumazenil positron emission tomography visualizes frontal epileptogenic regions. Epilepsia. 36:1995;1225-1232.
163. Richardson M. P., Koepp M. J., Brooks D. J., Duncan J. S. 11C-flumazenil PET in neocortical epilepsy. Neurology. 51:1998;485-492.
164. Savic I., Svanborg E., Thorell J. O. Cortical benzodiazepine receptor changes are related to frequency of partial seizures: a positron emission tomography study. Epilepsia. 37:1996;236-244.
165. Ryvlin P., Bouvard S., Le Bars D., De Lamerie G., Gregoire M. C. et al. Clinical utility of flumazenil-PET versus [18F]fluorodeoxyglucose-PET and MRI in refractory partial epilepsy. A prospective study in 100 patients. Brain. 121:1998;2067-2081.
166. Liu Z., Vergnes M., Depaulis A., Marescaux C. Involvement of intrathalamic GABA-B transmission in the control of absence seizures in the rat. Neuroscience. 48:1992;87-93.
167. Prevett M. C., Lammertsma A. A., Brooks D. J., Bartenstein P. A., Patsalos P. N. et al. Benzodiazepine-GABAA receptors in idiopathic generalised epilepsy measured with [11C]flumazenil and positron emission tomography. Epilepsia. 36:1995;113-121.
168. Savic I., Widen L., Thorell J. O., Blomqvist G., Ericson K. et al. Cortical benzodiazepine receptor binding in patients with generalized and partial epilepsy. Epilepsia. 31:1990;724-730.
169. Savic I., Pauli S., Thorell J. O., Blomqvist G. In vivo demonstration of altered benzodiazepine receptor density in patients with generalised epilepsy. Journal of Neurology, Neurosurgery and Psychiatry. 57:1994;797-804.
170. Liu Z., Vergnes M., Depaulis A., Marescaux C. Evidence for a critical role of GABAergic transmission within the thalamus in the genesis and control of absence seizures in the rat. Brain Research. 545:1991;1-7.
171. Prevett M. C., Lammertsma A. A., Brooks D. J., Cunnungham V. J., Fish D. R. et al. Benzodiazepine-GABAA receptor binding during absence seizures. Epilepsia. 36:1995;592-599.
172. Bajorek J. G., Lee R. L., Lomax P. Neuropeptides: anticonvulsant and convulsant mechanisms in epileptic model systems and in humans. Advances in Neurology. 44:1986;489-500.
173. Frost J. J., Mayberg H. S., Fisher R. S., Douglass K. H., Dannals R. F. et al. Mu-opiate receptors measured by positron emission tomography are increased in temporal lobe epilepsy. Annals of Neurology. 23:1988;231-237.
174. Mayberg H. S., Sadzot B., Meltzer C. C., Fisher R. S., Lesser R. P. et al. Quantification of mu and non-mu opiate receptors in temporal lobe epilepsy using positron emission tomography. Annals of Neurology. 30:1991;3-11.
175. Bartenstein P. A., Prevett M. C., Duncan J. S., Hajek M., Wieser H. G. Quantification of opiate receptors in two patients with mesiobasal temporal lobe epilepsy, before and after selective amygdalohippocampectomy, using positron emission tomography. Epilepsy Research. 18:1994;119-125.
176. Theodore W. H., Carson R. E., Andreasen P., Zametkin A., Blasberg R. et al. PET imaging of opiate receptor binding in human epilepsy using [18F]cyclofoxy. Epilepsy Research. 13:1992;129-139.
177. Koepp M. J., Richardson M. P., Brooks D. J., Duncan J. S. Focal cortical release of endogenous opioids during reading-induced seizures. Lancet. 352:1998;952-955.
178. Kumlien E., Bergstrom M., Lilja A. et al. Positron emission tomography with [11C] deuterium-deprenyl in temporal lobe epilepsy. Epilepsia. 36:1995;712-721.
179. Kumlien E., Hartvig P., Valind S., Oye I., Tedroff J. et al. NMDA-receptor activity visualized with (S)-[N-methyl-11C]ketamine and positron emission tomography in patients with medial temporal lobe epilepsy. Epilepsia. 40:1999;30-37.
180. Chugani D. C., Chugani H. T., Muzik O., Shah J. R., Shah A. K. et al. Imaging epileptogenic tubers in children with tuberous sclerosis complex using alpha-[11C]-methyl-L-tryptophan positron emission tomography. Annals of Neurology. 44:1998;858-866.
181. Iinuma K., Yokoyama H., Otsuki T., Yanai K., Watanabe T. et al. Histamine H1 receptors in complex partial seizures. Lancet. 341:1993;238.
182. Banati R. B., Goerres G. W., Myers R., Gunn R. N., Turkheimer F. E. et al. [11C](R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen's encephalitis. Neurology. 53:1999;2199-2203.